Canaccord Genuity Reiterates a 'Buy' on Anacor Pharmaceuticals (ANAC); Potential From Novel Dermatologic Drug Development Pipeline.

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/14/2026

1. JPM
2. ERAS
3. IBM
4. TREX
5. SPRO
6. ORCL
7. AAPL
8. WFC
9. KKR
10. BAC

Go back to Canaccord Genuity Reiterates a 'Buy' on Anacor Pharmaceuticals (ANAC); Potential From Novel Dermatologic Drug Development Pipeline.